- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Emerging Potential: Changing Lives One Story, One Therapeutic at a Time
The 2023 Emerging Pharma Leaders share with the Pharmaceutical Executive editors what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more. (This is the audio-only Pharm Exec Podcast episode!)
Each year, Pharmaceutical Executive recognizes up-and-coming leaders who are vital to the future of the pharmaceutical and biotech industry in the Emerging Pharma Leaders (EPL) Awards. Nominations are judged by three members of the Editorial Advisory Board as well as a former EPL representative. This year, five winners were selected, all of whom had incredible journeys to share with the editorial team.
The Pharm Exec team would like to congratulate the 2023 Emerging Pharma Leaders:
- Natasha A. Hernday, chief business officer, Seagen
- Simon Holland, vice president, women's health commercial lead, Organon
- Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio
- Frank Watanabe, president and CEO, Arcutis Biotherapeutics
- Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics
In this episode of the Pharm Exec Podcast, Meg Rivers, managing editor, and the editorial team speak with the EPL winners, asking each about:
- Their current role and responsibilities
- What makes a good leader
- What has made them the proudest in their career
- Lessons they wish they had known when starting out
- What’s next for them in their career
Sponsor
Watch the video version of this podcast
Read about the 2023 Emerging Pharma Leaders
- Natasha A. Hernday, chief business officer, Seagen
- Simon Holland, vice president, women's health commercial lead, Organon
- Justin To, chief operating officer, skeletal dysplasias and gene therapy, Bridge Bio
- Frank Watanabe, president and CEO, Arcutis Biotherapeutics
- Hanadie Yousef, PhD, co-founder and CEO, Juvena Therapeutics
About the Pharm Exec Podcast
The editors of Pharmaceutical Executive bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
